Subjective and objective effects of radioiodine therapy on the sense of smell
European Archives of Oto-Rhino-Laryngology · 2024
DOI: 10.1007/s00405-024-08761-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Archives of Oto-Rhino-Laryngology, 2024. Verfasst von Azin Tabari und 7 weiteren Autor:innen. Beteiligte Einrichtung: Otorhinolaryngology Research Center, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran. Hauptthemen laut MEDLINE: Iodine Radioisotopes, Olfaction Disorders, Quality of Life, Thyroid Neoplasms. Die Arbeit nennt 27 Literaturangaben. Gefördert von: Tehran University of Medical Sciences and Health Services.
Abstract (Originalsprache)
PURPOSE: Evaluating the impact of radioiodine therapy (RIT) on olfactory function in thyroid cancer patients through quantitative and qualitative olfactory tests. METHOD: In this cohort study, patients with thyroid cancer were included. Demographic, clinical, and laboratory data were collected. To subjectively evaluate the olfactory changes aftter RIT, the Visual Analog Scale (VAS), Self-Reported Mini-Olfactory Questionnaire (self-MOQ), and the University of Washington Quality of Life Questionnaire (UW-QOL) were assessed. Out of UW-QOL questions those related to saliva, taste, and overall health condition were analysed. For objective assessment, patients underwent both the Butanol Threshold Test (BTT) and the a version of Smell Identification Test (SIT). Patients were assessed before, one month, and six months after RIT. RESULTS: Ninety eight patients were included (Male = 17). A statistically significant decrement was observed in olfaction based on the VAS, between the baseline and one (pvalue = 0.015) and six months (pvalue = 0.031) of follow-up. Additionally, saliva (pvalue = 0.001), taste (pvalue = 0.000), and overall health condition (pvalue = 0.010) significantly decreased one-month after RIT. The measures were not different between the baseline and 6-month follow up and the improvement of index of taste was significant from 1-month to 6-months follow ups (pvalue = 0.000). However, none of the objective tests (the BTT and the SIT) indicated a significant decline in olfaction during the follow up. CONCLUSION: A subjective RIT related decrease in smell function, taste, and saliva production was documented without any objective olfactory dysfunction.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Otorhinolaryngology Research Center, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.
- Department of Nuclear Medicine, Imam Khomeini Hospital Complex, Vali-Asr Hospital, Tehran University of Medical Sciences, Tehran, Iran.
- Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
- Department of Nuclear Medicine, Imam Khomeini Hospital Complex, Vali-Asr Hospital, Tehran University of Medical Sciences, Tehran, Iran. meabbasi@sina.tums.ac.ir.
Förderung
- Tehran University of Medical Sciences and Health Services
Zitieren
APA
Tabari, A., Farrokh, F., Bakhshi, M., Tabari, A., Sadrehosseini, S. M., Saedi, B., Farzanehfar, S., & Abbasi, M. (2024). Subjective and objective effects of radioiodine therapy on the sense of smell. European Archives of Oto-Rhino-Laryngology. https://doi.org/10.1007/s00405-024-08761-3
Vancouver
Tabari A, Farrokh F, Bakhshi M, Tabari A, Sadrehosseini SM, Saedi B, et al. Subjective and objective effects of radioiodine therapy on the sense of smell. European Archives of Oto-Rhino-Laryngology. 2024. doi:10.1007/s00405-024-08761-3
BibTeX
@article{Tabari2024,
author = {Tabari, Azin and Farrokh, Fatemeh and Bakhshi, Mohsen and Tabari, Azadeh and Sadrehosseini, Seyed Mousa and Saedi, Babak and Farzanehfar, Saeed and Abbasi, Mehrshad},
title = {Subjective and objective effects of radioiodine therapy on the sense of smell},
journal = {European Archives of Oto-Rhino-Laryngology},
year = {2024},
doi = {10.1007/s00405-024-08761-3}
}
EUVIMED